Our story.

Genomic information is only one part of a patient’s story.

GenoXvision is a digital health company founded in 2023, building on years of experience in genetics and healthcare. Our journey began with a focus on the interpretation of genomic data for personalised cancer care.

As we worked alongside oncologists and other clinical specialists, we recognised a broader challenge. Genomic information is only one part of a cancer patient’s story. Pathology, imaging, molecular findings, treatment history, response and follow-up often sit across different reports, systems and stages of care. This fragmentation can make it difficult for multidisciplinary teams to work from the same complete and up-to-date clinical picture.

GenoXvision evolved into a longitudinal oncology platform designed to work alongside existing hospital systems rather than replace them, structuring and connecting these different layers of information into a single patient record that gives clinical teams a clearer view of the cancer journey.

As the platform evolved, we identified another gap: visibility often decreases once patients leave the clinical setting. This led us to incorporate continuous monitoring, helping care teams stay connected with patients during treatment and follow-up.

Today, our goal is to give cancer care teams a clearer, more connected view of each patient’s story, while building a structured oncology data foundation that can support clinical care, real-world evidence and future research — built for the realities of healthcare systems across the GCC and MENA region.